HDFN incidence in neonates with blood type A or B and raised TcB levels was 6.17%. Transcutaneous bilirubin (TcB) is an effective screening tool for hyperbilirubinemia and hemolytic disease of the ...
A subgroup of patients with HD with global memory impairments, particularly consolidation deficits, showed more medial temporal lobe atrophy. Patients with Huntington disease (HD) show deficits in ...
A diagnosis of ATTR-CM in a more recent era was associated with older age, White race, wild‐type disease, and tafamidis treatment. The survival of patients diagnosed with transthyretin-mediated ...
The diagnosis and management of CIDP are complex and best addressed by an interprofessional health care team that includes neurologists, neuromuscular specialists, physical medicine and rehabilitation ...
Between 2001 to 2011, annual age-adjusted incidence increased from 0.55/100,000 to 0.78/100,000, demonstrating an increasing trend with age. Incidence peaks in individuals over 70 years of age ...
Individuals with advanced liver disease may also experience significant weight loss due to nausea and poor appetite. Candidates for liver transplantation may need to gain weight to optimize surgical ...
Both a higher Charlson Comorbidity Index score and older age showed a significant prognostic impact on all-cause mortality. Chronic lymphocytic leukemia (CLL) progression was the leading cause of ...
People with myasthenia gravis (MG) show significant changes in blood pressure variability both at rest and in response to orthostatic stress, found a new study published in the journal Neurological ...
(L-R) Rare Disease Advisor senior correspondent Larry Luxner, patient columnists Alithea Athans, Tara Keith and Tom Bartlett, and director of advocacy relations Vera Luxner (Photo by Riya Ajmera) ...
Dimitrios Karussis, MD, PhD, head of the Multiple Sclerosis Center at Hadassah University Hospital in Jerusalem, Israel (Photo by Larry Luxner) Patients with multiple sclerosis who were injected with ...
The US Food and Drug Administration (FDA) has cleared AnemoCheck Home for patients with sickle cell disease (SCD), iron deficiency anemia, vitamin B12 deficiency anemia, folate deficiency anemia, and ...
Nearly two-thirds of adult patients on crinecerfont achieved glucocorticoid doses within the physiologic range, compared to just 18% on placebo. The US Food and Drug Administration (FDA) has approved ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback